PILOT-STUDY OF A CONTINUOUS 5-DAY INTRAVENOUS-INFUSION OF ETOPOSIDE CONCOMITANT WITH CISPLATIN IN SELECTED PATIENTS WITH ADVANCED CANCER

被引：18

作者：

CREAGAN, ET

RICHARDSON, RL

KOVACH, JS

机构：

来源：

关键词：

D O I：

10.1200/JCO.1988.6.7.1197

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1197 / 1201

页数：5

共 30 条

[1] ETOPOSIDE - CHEMISTRY, PRE-CLINICAL AND CLINICAL-PHARMACOLOGY
ACHTERRATH, W
NIEDERLE, N
RAETTIG, R
HILGARD, P
[J]. CANCER TREATMENT REVIEWS, 1982, 9 : 3 - 13
[2] A PHASE-I TRIAL OF CONTINUOUS INFUSION VP16-213 (ETOPOSIDE)
AISNER, J
VANECHO, DA
WHITACRE, M
WIERNIK, PH
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) : 157 - 160
[3] ARBUS MH, 1986, COMMUNICATION 0204
[4] ETOPOSIDE (VP-16) AND CISPLATIN IN PREVIOUSLY TREATED SMALL-CELL LUNG-CANCER - CLINICAL-TRIAL AND INVITRO CORRELATES
BATIST, G
CARNEY, DN
COWAN, KH
VEACH, SR
GILLIOM, M
BUNN, PA
IHDE, DC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (06) : 982 - 986
[5] DECONTI RC, 1973, CANCER RES, V33, P1310
[6] DOMBERNOWSKY P, 1973, ACTA PATH MICRO IM A, VA 81, P715
[7] DREWINKO B, 1973, CANCER RES, V33, P3091
[8] EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO
[9] 2-4
[10] EINHORN LH, 1984, P AM ASSOC CANC RES, V25, P174